日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetically edited CD34+ cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells

经过基因编辑的 CD34+ 细胞源自人类 iPS 细胞(在体内但不是体外),可植入并分化为抗 HIV 细胞

Maelig G Morvan, Fernando Teque, Lin Ye, Mary E Moreno, Jiaming Wang, Scott VandenBerg, Cheryl A Stoddart, Yuet Wai Kan, Jay A Levy

The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells

CD8+细胞的非细胞毒性抗病毒反应会影响受感染CD4+细胞中RNA聚合酶II介导的人类免疫缺陷病毒转录。

Blazek, Dalibor; Teque, Fernando; Mackewicz, Carl; Peterlin, Matija; Levy, Jay A

Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits

基于 HIV-1 包膜近端外部区域的化学修饰肽可在兔体内诱导高滴度、表位特异性非中和抗体

Vincent J Venditto, Lindsay Wieczorek, Sebastian Molnar, Fernando Teque, Gary Landucci, Douglas S Watson, Donald Forthal, Victoria R Polonis, Jay A Levy, Francis C Szoka Jr

Nevirapine inhibits the anti-HIV activity of CD8+ cells

奈韦拉平抑制 CD8+ 细胞的抗 HIV 活性

Lianxing Liu, Lin Wang, Liusheng Huang, Vincent Siu, Fernando Teque, Francesca T Aweeka, Jay A Levy

CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons

CD8(+) 淋巴细胞通过分泌 I 型干扰素抑制人类免疫缺陷病毒 1 复制

M Scott Killian, Fernando Teque, Robert L Walker, Paul S Meltzer, J Keith Killian

Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state

在HIV-1感染者中,浆细胞样树突状细胞的数量以及对Toll样受体7和9激动剂的反应随临床状态而变化。

Kaushik, Shweta; Teque, Fernando; Patel, Mira; Fujimura, Sue H; Schmidt, Barbara; Levy, Jay A

Transfection optimization for primary human CD8+ cells

人类原代 CD8+ 细胞的转染优化

Lianxing Liu, Carl Johnson, Sue Fujimura, Fernando Teque, Jay A Levy